Skip to Main Content

Author Details

Xu Zhang
2015
15
10
PMIDPaper TitleJournal TitlePublished Year
36470425Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.J Biol Chem2023
35139387Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.Cell Rep2022
34638461Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma.Cancers2021
33850265SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma.Oncogene2021
33727228Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance.Cancer Res2021
34391887Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.Mol Cell Proteomics2021
30840888APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors.Cell Rep2019
30617155Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V.Mol Cell Proteomics2019
29660496Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma.J Proteomics2018
29900338Dataset describing the development, optimization and application of SRM/MRM based targeted proteomics strategy for quantification of potential biomarkers of EGFR TKI sensitivity.Data Brief2018
28331001Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response.Mol Cell Proteomics2017
28819023Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors.Cancer Res2017
25605897Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins.Proc Natl Acad Sci U S A2015
25735773Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.Cancer Discov2015
25404012Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.Proteomics2015
  • 1 - 15 of 15

Recommended Authors

Collaborators

Co-authored papers 15
Co-authored papers 10
Co-authored papers 7
Co-authored papers 6
Co-authored papers 4
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Co-authored papers 2
University of Victoria
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Co-authored papers 1
Georgetown University Medical Center
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
University of the Basque Country (UPV/EHU)
Co-authored papers 1
Co-authored papers 1
Adelaide Medical School, University of Adelaide
Co-authored papers 1
Columbia University
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research, National Cancer Institute-Frederick
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 1
Meyer Cancer Center
Co-authored papers 1
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Co-authored papers 1